Improved control of SARS-CoV-2 by treatment with a nucleocapsid-specific monoclonal antibody.
Dangi T, Sanchez S, Class J, Richner M, Visvabharathy L, Chung YR, Bentley K, Stanton RJ, Koralnik IJ, Richner JM, Penaloza-MacMaster P.
Dangi T, et al. Among authors: richner m.
J Clin Invest. 2022 Dec 1;132(23):e162282. doi: 10.1172/JCI162282.
J Clin Invest. 2022.
PMID: 36219482
Free PMC article.